-
Coface offers excess profit in an unloved sector
Coface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotech
Biotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
Share tips 2026: this week’s top stock picks
Share tips Share tips 2026: MoneyWeek’s roundup of the top stock picks this week – here’s what the experts think you should buy
Share tips -
Netflix shares fall as guidance disappoints
Despite an earnings beat, shares in Netflix fell overnight as the company’s margin outlook fell short of expectations
-
The top stocks of 2025 - did you pick a winner?
Last year was a chaotic one for the stock market, but which stocks did investors buy the most of?
-
Profit from pest control with Rentokil Initial
Rentokil Initial is set for global expansion and offers strong sales growth
-
Tap income and capital growth in markets worldwide
Opinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust
Opinion -
PayPoint: A promising stock for income-seekers
PayPoint, a household name across Britain, is moving away from its traditional roots toward a digital future. Investors after a steady income should buy in
-
Taiwan Semiconductor shares jump on AI outlook
TSMC, Nvidia’s key supplier, has beaten on earnings and poured cold water on talk of an AI bubble
